Structure-based design of potent and selective CGRP receptor antagonists for the treatment of migraine

被引：0
|
作者：
Bell, Ian [1 ]
机构：
[1] Merck & Co Inc, Discovery Chem, West Point, PA USA
来源：
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY | 2019年 / 258卷
关键词：
D O I：
暂无
中图分类号：
O6 [化学];
学科分类号：
0703 ;
摘要：
235-MEDI
引用
收藏
页数：1
相关论文
共 50 条
  • [41] Patient Sex in Prescribing CGRP Receptor Antagonists for Migraine
    Lanteri-Minet, Michel
    Wang, Shuu-Jiun
    Martelletti, Paolo
    [J]. JAMA NEUROLOGY, 2024,
  • [42] CGRP Receptor Antagonists: Toward a Novel Migraine Therapy
    Salvatore, C. A.
    Kane, S. A.
    [J]. CURRENT PHARMACEUTICAL BIOTECHNOLOGY, 2011, 12 (10) : 1671 - 1680
  • [43] Structure-based design of Trifarotene (CD5789), a potent and selective RARγ agonist for the treatment of acne
    Thoreau, Etienne
    Arlabosse, Jean-Marie
    Bouix-Peter, Claire
    Chambon, Sandrine
    Chantalat, Laurent
    Daver, Sebastien
    Dumais, Laurence
    Duvert, Gwenaelle
    Feret, Angelique
    Ouvry, Gilles
    Pascau, Jonathan
    Raffin, Catherine
    Rodeville, Nicolas
    Soulet, Catherine
    Tabet, Samuel
    Talano, Sandrine
    Portal, Thibaud
    [J]. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2018, 28 (10) : 1736 - 1741
  • [44] CGRP Receptor Antagonists and 5-HT1F Receptor Agonist in the Treatment of Migraine
    Capi, Matilde
    De Angelis, Valerio
    De Bernardini, Donatella
    De Luca, Ottavia
    Cipolla, Fabiola
    Lionetto, Luana
    Simmaco, Maurizio
    Martelletti, Paolo
    [J]. JOURNAL OF CLINICAL MEDICINE, 2021, 10 (07)
  • [45] Identification of potent and selective retinoic acid receptor gamma (RARγ) antagonists for the treatment of osteoarthritis pain using structure based drug design
    Hughes, Norman E.
    Bleisch, Thomas J.
    Jones, Scott A.
    Richardson, Timothy I.
    Doti, Robert A.
    Wang, Yong
    Stout, Stephanie L.
    Durst, Gregory L.
    Chambers, Mark G.
    Oskins, Jennifer L.
    Lin, Chaohua
    Adams, Lisa A.
    Page, Todd J.
    Barr, Robert J.
    Zink, Richard W.
    Osborne, Harold
    Montrose-Rafizadeh, Chahrzad
    Norman, Bryan H.
    [J]. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2016, 26 (14) : 3274 - 3277
  • [46] Structure-based design of selective and potent inhibitors of protein-tyrosine phosphatase β
    Lund, IK
    Andersen, HS
    Iversen, LF
    Olsen, OH
    Moller, KB
    Pedersen, AK
    Ge, Y
    Holsworth, DD
    Newman, MJ
    Axe, FU
    Moller, NPH
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2004, 279 (23) : 24226 - 24235
  • [47] Structure-based design of potent and selective tankyrase inhibitors to target the Wnt pathway
    Chakka, Nagasree
    [J]. ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2014, 248
  • [48] Structure-based design of potent CDK4 selective inhibitor.
    Honma, T
    Hayashi, K
    Kawanishi, N
    Yoshizumi, T
    Hashimoto, N
    Sugimoto, T
    Nakamura, K
    Takaki, T
    Machida, T
    Fukasawa, K
    Hirai, H
    Iwama, T
    Ikeura, C
    Ikuta, M
    Kamata, K
    Suzuki-Takahashi, I
    Hayama, T
    [J]. ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2001, 221 : U24 - U24
  • [49] Structure-based design and discovery of potent and selective KDM5 inhibitors
    Nie, Zhe
    Shi, Lihong
    Lai, Chon
    O'Connell, Shawn M.
    Xu, Jiangchun
    Stansfield, Ryan K.
    Hosfield, David J.
    Veal, James M.
    Stafford, Jeffrey A.
    [J]. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2018, 28 (09) : 1490 - 1494
  • [50] Structure-Based Design and Synthesis of Potent and Selective Matrix Metalloproteinase 13 Inhibitors
    Choi, Jun Yong
    Fuerst, Rita
    Knapinska, Anna M.
    Taylor, Alexander B.
    Smith, Lyndsay
    Cao, Xiaohang
    Hart, P. John
    Fields, Gregg B.
    Roush, William R.
    [J]. JOURNAL OF MEDICINAL CHEMISTRY, 2017, 60 (13) : 5816 - 5825
12345